Publicaciones en las que colabora con Mercedes Iñarrairaegui Bastarrica (31)

2023

  1. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

2022

  1. A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

    Scientific Reports, Vol. 12, Núm. 1

  2. Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

    Journal for immunotherapy of cancer, Vol. 10, Núm. 11

  3. Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes

    Langenbeck's Archives of Surgery, Vol. 407, Núm. 3, pp. 1099-1111

2021

  1. 3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 10, pp. 3048-3057

  2. The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning

    EJNMMI Research, Vol. 11, Núm. 1

2020

  1. The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT

    CardioVascular and Interventional Radiology, Vol. 43, Núm. 8, pp. 1165-1172

2018

  1. Pneumatocele during sorafenib therapy: First report of an unusual complication

    Oncotarget, Vol. 9, Núm. 5, pp. 6652-6656

  2. Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 10, pp. 1721-1730

2017

  1. Evaluation of the rabbit liver by direct portography and contrast-enhanced computed tomography: anatomical variations of the portal system and hepatic volume quantification

    European Radiology Experimental, Vol. 1, Núm. 1

  2. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients

    Journal of Vascular and Interventional Radiology, Vol. 28, Núm. 11, pp. 1536-1542

  3. Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

    Translational Research, Vol. 188, pp. 80-91.e2

2015

  1. Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

    Liver International, Vol. 35, Núm. 6, pp. 1715-1721

  2. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

    Liver International, Vol. 35, Núm. 5, pp. 1590-1596

2014

  1. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension

    HPB, Vol. 16, Núm. 3, pp. 243-249

  2. Radioembolization: Concepts and Procedures

    Therapeutic Nuclear Medicine (Springer), pp. 361-377

2013

  1. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma

    Journal of Hepatology, Vol. 59, Núm. 4, pp. 753-761

  2. Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology, Vol. 57, Núm. 3, pp. 1078-1087

  3. Reply to: "pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres"

    Journal of Hepatology

2012

  1. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation

    Transplantation Proceedings